Month: February 2021

AUSTIN, Texas, Feb. 17, 2021 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ: CHUY) today announced that it will host a conference call to discuss fourth quarter and fiscal year 2020 financial results on Thursday, March 4, 2021 at 5:00 PM Eastern Time. A press release with fourth quarter and fiscal year 2020 financial results will be issued that same day after the market close. Hosting the call will be Steve Hislop, President and Chief Executive Officer, and Jon Howie, Vice President and Chief Financial Officer.The conference call can be accessed live over the phone by dialing 877-300-8521 or for international callers by dialing 412-317-6026. A replay will be available after the call and can be accessed by dialing 844-512-2921 or for international callers by dialing 412-317-6671; the passcode is 10152174. The replay will be available...

EWING, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to participate and host investor meetings at the SVB Leerink 10th Annual Virtual Global Healthcare Conference being held on February 22-26, 2021.About Antares PharmaAntares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical...

BOSTON, Feb. 17, 2021 (GLOBE NEWSWIRE) — Radius Health, Inc. (Nasdaq: RDUS), today announced that it will provide a corporate update at the 10th Annual SVB Leerink Global Healthcare Conference at 10:40 a.m. ET on Thursday, February 25, 2021.A live webcast of the presentation will be available by visiting the Investors section of the Company’s website at https://ir.radiuspharm.com/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.About RadiusRadius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with...

BELGRADE, Mont., Feb. 17, 2021 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2020, before the open of the financial markets on Wednesday, February 24, 2021.Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Wednesday, February 24 at 9:00 AM ET to review results.Conference Call DetailsDate: Wednesday, February 24, 2021 – 9:00 AM ETDial-in: 877-407-6184International dial-in: 201-389-0877Conference Call Name: Xtant Medical Fourth Quarter 2020 Financial ResultsWebcast Registration: Click HereFollowing...

ATLANTA, Feb. 17, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, announces today that it will report fourth quarter and full year 2020 financial results on Wednesday, February 24, 2021 after the market close.Management will host a conference call at 9:00 AM ET on Thursday, February 25, 2021 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question and answer session.Participants are asked to pre-register for the call.Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without...

SAINT LAURENT, Quebec, Feb. 17, 2021 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that the United States Patent and Trademark Office (“USPTO”) has granted a Notice of Allowance for US Patent Application 16/110,737, entitled “Film Dosage Form with Extended Release Mucoadhesive Particles.”This film formulation patent covers novel disintegrating oral film formulations designed for the transmucosal absorption of drug, especially tetrahydrocannabinol (THC), and is intended to protect IntelGenx’s DisinteQTM products.“DisinteQ™ has been specifically designed to optimize mucosal absorption of drug by utilizing controlled erosion as a mechanism to release THC into the oral cavity, thus avoiding having a portion of the drug being swallowed and, thereby, minimizing the amount of THC that becomes...

CHARLOTTE, N.C., Feb. 17, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC today announced the launch of a modernized brand identity reflecting the firm’s renewed culture, legacy of innovation and enduring commitment to advisors. As American investors increasingly seek objective advice from a trusted financial advisor, the independent market leader is reimagining the future of advice, in partnership with advisors, with brand positioning that emphasizes to advisors, “Your greatness is our goal.” “With a renewed culture and sense of purpose, a constantly evolving suite of services and technologies, and even new ways of affiliating with us, we have reshaped our vision of what is possible for the future of our industry, and our collective place in it,” said Heather Randolph Carter, LPL Financial executive vice president and Chief Marketing...